A paradigm shift in therapeutic vaccination of cancer patients: the need to apply therapeutic vaccination strategies in the preventive setting
Author:
Publisher
Wiley
Subject
Immunology,Immunology and Allergy
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-065X.2008.00605.x/fullpdf
Reference90 articles.
1. Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides
2. Phase II prostate cancer vaccine trial: Report of a study involving 37 patients with disease recurrence following primary treatment
3. Immunotherapy of Hormone-Refractory Prostate Cancer With Antigen-Loaded Dendritic Cells
4. Dendritic Cell-Based Xenoantigen Vaccination for Prostate Cancer Immunotherapy
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Cancer and vaccines. Present and future br;MED BALEAR;2023
2. Personalized dendritic cell vaccination in cancer therapy: An evidence-based research study;Journal of Cancer Research and Therapeutics;2023
3. Strategies for developing and optimizing cancer vaccines;F1000Research;2019-05-13
4. Concluding Remarks and Future Perspectives on Therapeutic Cancer Vaccines;Vaccines for Cancer Immunotherapy;2019
5. Vaccines, Adjuvants, and Delivery Systems;Vaccines for Cancer Immunotherapy;2019
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3